Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Study of Immunotherapy With hA20 Administered Once Weekly for 4 Consecutive Weeks in Patients With CD20+ Non- Hodgkin's Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00596804
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:32.036409+00:00
Published At
2021-08-18T00:00:00+00:00
Record Updated At
2021-08-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non-Hodgkin\u0027s Lymphoma", "Lymphoma, Diffuse", "Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-08-18"
protocolSection.identificationModule.nctId
"NCT00596804"
protocolSection.identificationModule.officialTitle
"A Phase I Study of Immunotherapy With hA20 Administered Once Weekly for 4 Consecutive Weeks in Patients With CD20+ Non- Hodgkin\u0027s Lymphoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Non-Hodgkin's Lymphoma (protocolSection.conditionsModule.conditions)
  • Lymphoma, Diffuse (protocolSection.conditionsModule.conditions)
  • Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.